Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease
Jiang Du, Yu Ji, Liang Qiao, et al.
Liver International (2019) Vol. 40, Iss. 2, pp. 271-280
Open Access | Times Cited: 21

Showing 21 citing articles:

The role of lysosomes in metabolic and autoimmune diseases
Frédéric Gros, Sylviane Muller
Nature Reviews Nephrology (2023) Vol. 19, Iss. 6, pp. 366-383
Closed Access | Times Cited: 82
Self-Assembly of a Dual-Targeting and Self-Calibrating Ratiometric Polymer Nanoprobe for Accurate Hypochlorous Acid Imaging
Hui Liu, Peisheng Zhang, Chonghua Zhang, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 41, pp. 45822-45829
Closed Access | Times Cited: 114
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Mariia Uzhytchak, Barbora Smolková, Mariia Lunová, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114828-114828
Closed Access | Times Cited: 30
The relevance of organelle interactions in cellular senescence
Jiewu Huang, Ping Meng, Cheng Wang, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 2445-2464
Open Access | Times Cited: 30
A red-emission and viscosity-ultrasensitive probe for identifying non-alcoholic fatty liver via imaging lysosomal viscosity
Lei Hu, Jing Yang, Cuifeng Zhang, et al.
Sensors and Actuators B Chemical (2023) Vol. 398, pp. 134776-134776
Closed Access | Times Cited: 12
Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD
Marica Meroni, Emilia Rita De, Federica Chiappori, et al.
Obesity (2024) Vol. 32, Iss. 5, pp. 923-937
Open Access | Times Cited: 4
Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats
Xingjian Wen, Hejing Liu, Luo Xiao-ling, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
Febuxostat alleviate metabolic dysfunction-associated steatohepatitis in rat model via targeting inflammation, cell death, and intestinal barrier dysfunction
Marwa Matboli, Maha Saad, Manar Fouad Ahmed, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118086-118086
Closed Access
HGF Secreted by Menstrual Blood-Derived Endometrial Stem Cells Ameliorates Non-Alcoholic Fatty Liver Disease Through Downregulation of Hepatic Rnf186
Jiang Du, Yan Jiang, Xinlei Liu, et al.
Stem Cells (2022) Vol. 41, Iss. 2, pp. 153-168
Closed Access | Times Cited: 15
Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling
Xinlei Liu, Yan Zhang, MA Chunya, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 4, pp. 3113-3122
Closed Access | Times Cited: 14
Expression and functions of transient receptor potential channels in liver diseases
Wenhui Wang, Pengyu Liu, Yalin Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 445-459
Open Access | Times Cited: 14
The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12185-12185
Open Access | Times Cited: 13
SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR
Jingjing Song, Yupeng Liu, Juan Wan, et al.
Hepatology (2021) Vol. 74, Iss. 6, pp. 3091-3109
Closed Access | Times Cited: 18
Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease
Jiang Du, Xiang Ji, Bo Xu, et al.
Metabolism (2023) Vol. 152, pp. 155769-155769
Closed Access | Times Cited: 7
Resveratrol promotes lysosomal function via ER calcium-dependent TFEB activation to ameliorate lipid accumulation
Rong Shao, Jiahui Shi, Kaili Du, et al.
Biochemical Journal (2021) Vol. 478, Iss. 5, pp. 1159-1173
Open Access | Times Cited: 15
RNA nanomedicine in liver diseases
Anita K. Bakrania, Yulin Mo, Gang Zheng, et al.
Hepatology (2023)
Closed Access | Times Cited: 5
Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor
Aldo Prawira, Thi Bich Uyen Le, Rebecca Zhi Wen Ho, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 10, pp. 2955-2968
Open Access | Times Cited: 10
ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets
Caroline C. Duwaerts, Jessica L. Maiers
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 7
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion
Caifeng Zhang, Juanjuan Ji, Xue-Fang Du, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress
Masaki Tamitani, Takeshi Yamamoto, Naoki Yamamoto, et al.
Biochemistry and Biophysics Reports (2020) Vol. 23, pp. 100787-100787
Open Access | Times Cited: 10
Identifying Shared Risk Genes between Nonalcoholic Fatty Liver Disease and Metabolic Traits by Cross-Trait Association Analysis
Hongping Guo, Zu‐Guo Yu
Processes (2021) Vol. 9, Iss. 1, pp. 107-107
Open Access
Page 1

Scroll to top